Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy
Cowley, A.W.
Hypertension 6(2 Part 1): 137-139
1984
ISSN/ISBN: 0194-911X PMID: 6144630 Document Number: 224794
Document emailed within 1 workday
Related Documents
Bruynzeel, P.L. 1984: Changes in the beta-adrenergic system due to beta-adrenergic therapy: clinical consequences European Journal of Respiratory Diseases. Supplement 135: 62-71Watkins, R.W.; Sybertz, E.J.; Cook, J.; Pula, K.; Cedeno, K.; Tedesco, R.P.; McLeod, R. 1989: Role of beta 2-receptor stimulation in the peripheral vascular actions of the antihypertensive dilevalol Archives Internationales de Pharmacodynamie et de Therapie 302: 158-173
Dziki, A.J.; Lynch, W.H.; Ramsey, C.B.; Law, W.R. 1993: Beta-adrenergic-dependent and -independent actions of naloxone on perfusion during endotoxin shock Circulatory Shock 39(1): 29-38
Jäättelä, A.; Pyöräiä, K. 1976: The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone Duodecim; Laaketieteellinen Aikakauskirja 92(11): 597-603
Actis, E.; Amato, E.A.; Palmero, H.A.; Rebora, E.H.; Fernández Vidal, J.M. 1978: Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients Medicina 38(6 Pt 1): 673-678
Andersen, G.S.; Hartling, O.J.; Hein, H.O.; Leth, A. 1985: Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions Danish Medical Bulletin 32(5): 280-283
Mersmann, H.J. 1995: Species variation in mechanisms for modulation of growth by beta-adrenergic receptors Journal of Nutrition 125(6 Suppl): 1777s-1782s
Mickey, J.V.; Tate, R.; Mullikin, D.; Lefkowitz, R.J. 1976: Regulation of adenylate cyclase-coupled beta adrenergic receptor binding sites by beta adrenergic catecholamines in vitro Molecular Pharmacology 12(3): 409-419
Llamas, R. 1987: Mechanisms of the antilipolytic action of adenosine. its effect on adrenergic beta receptors in adipose tissue Gaceta Medica de Mexico 123(9-10): 229-232
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Pilipchuk, N.S.; Kliachkin, L.M.; Protsiuk, R.G. 1989: Mechanisms of the therapeutic and damaging (side effects) actions of inhalation aerosol therapy Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 21-24
Fogari, R.; Zoppi, A.; Pasotti, C.; Poletti, L.; Tettamanti, F.; Malamani, G.; Corradi, L. 1989: Plasma lipids during chronic antihypertensive therapy with different beta-blockers Journal of Cardiovascular Pharmacology 14(Suppl 7): S28-S32
Szymański, P.T. 1983: Beta adrenergic receptors in the rat myocardium. II. Determination of the kinetic parameters of interaction of J-125-labeled hydroxybenzylpindolol with beta adrenergic receptors Endokrynologia Polska 34(5): 305-314
Erikssen, J. 1970: Beta-adrenergic blocking therapy in thyrotoxicosis Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(11): 1206-1210
White, W.B. 1999: Circadian variation of blood pressure and the assessment of antihypertensive therapy Blood Pressure Monitoring 4 Suppl. 1: S3-S6
Kirch, W.; Von Gizycki, C. 1980: Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances International Journal of Clinical Pharmacology Therapy and Toxicology 18(5): 233-235
Suidan, J.S. 1989: Cardiopulmonary complications of selective beta 2 adrenergic tocolytic therapy Middle East Journal of Anaesthesiology 10(3): 247-259
Gabrusenko, S.A.; Naumov, V.G.; Krasnikova, T.L.; Kupriianenko, T.I.; Gadzhiev, A.B.; Mazaev, A.V.; Mukharliamov, N.M. 1990: Cellular beta-adrenergic receptor complex in patients with heart failure and its changes during digoxin therapy Kardiologiia 30(7): 67-72
Barnes, P.J.; Dollery, C.T.; MacDermot, J. 1980: Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma Nature 285(5766): 569-571
Ennezat, P.-V.; Auffray, J.-L.; Darchis, J.; Rousselle, M.; Gonin, X.; Aubert, J.-M.; Bauchart, J.-J.; Bauters, C.; Van Belle, E.; Asseman, P. 2006: Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction? Therapie 61(3): 191-194